|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA11000573
|
Hentriacontane
|
Hentriacontane
|
|
C31H64
|
436.500801
|
|
LMFA01030741
|
9E-Octadecen-12-ynoic acid
|
9E-Octadecen-12-ynoic acid
|
FA 18:3
|
C18H30O2
|
278.224581
|
|
LMFA01030741
|
9E-Octadecen-12-ynoic acid
|
9E-Octadecen-12-ynoic acid
|
FA 18:3
|
C18H30O2
|
278.224581
|
|
LMFA01030686
|
Behenolic acid
|
Docos-13-ynoic acid
|
FA 22:2
|
C22H40O2
|
336.302831
|
|
LMFA13000002
|
Lanceolitol A2
|
D-myo-inositol-2-O-tetradecanoyl-1-O-beta-D-xylopyranoside
|
|
C25H46O11
|
522.304016
|
|
LMFA05000059
|
3Z-hexenol
|
3Z-hexenol
|
FOH 6:1
|
C6H12O
|
100.088815
|
|
LMFA11000345
|
2-Methylhexacosane
|
2-Methylhexacosane
|
|
C27H56
|
380.438201
|
|
LMFA13000001
|
Lanceolitol A1
|
D-myo-inositol-2-O-dodecanoyl-1-O-beta-D-xylopyranoside
|
|
C23H42O11
|
494.272716
|
|
LMFA13000003
|
Lanceolitol A3
|
D-myo-inositol-2-O-14-methylpentadecanoyl-1-O-beta-D-xylopyranoside
|
|
C27H50O11
|
550.335316
|
|
LMFA13000004
|
Lanceolitol A4
|
D-myo-inositol-2-O-10-methylpentadecanoyl-1-O-beta-D-xylopyranoside
|
|
C27H50O11
|
550.335316
|
|
LMFA13000005
|
Lanceolitol A5
|
D-myo-inositol-2-O-9-methylheptadecanoyl-1-O-beta-D-xylopyranoside
|
|
C29H54O11
|
578.366616
|
|
LMFA13000006
|
Lanceolitol A6
|
D-myo-inositol-2-O-16-methylheptadecanoyl-1-O-beta-D-xylopyranoside
|
|
C29H54O11
|
578.366616
|
|
LMFA13000007
|
Lanceolitol A7
|
D-myo-inositol-2-O-eicosanoyl-1-O-beta-D-xylopyranoside
|
|
C31H58O11
|
606.397916
|
|
LMFA13000008
|
Lanceolitol B1
|
D-myo-inositol-2-O-dodecanoyl-1-O-beta-D-glucopyranoside
|
|
C24H44O12
|
524.283281
|
|
LMFA13000010
|
Lanceolitol B3
|
D-myo-inositol-2-O-14-methylpentadecanoyl-1-O-beta-D-glucopyranoside
|
|
C28H52O12
|
580.345881
|
|
LMFA13000011
|
Lanceolitol B4
|
D-myo-inositol-2-O-10-methylpentadecanoyl-1-O-beta-D-glucopyranoside
|
|
C28H52O12
|
580.345881
|
|
LMFA05000063
|
6-[5]-ladderane-1-hexanol
|
6-[5]-ladderane-1-hexanol
|
FOH 18:5
|
C18H28O
|
260.214015
|
|
LMFA13000012
|
Lanceolitol B5
|
D-myo-inositol-2-O-9-methylheptadecanoyl-1-O-beta-D-glucopyranoside
|
|
C30H56O12
|
608.377181
|
|
LMFA13000013
|
Lanceolitol B6
|
D-myo-inositol-2-O-16-methylheptadecanoyl-1-O-beta-D-glucopyranoside
|
|
C30H56O12
|
608.377181
|
|
LMFA13000014
|
Lanceolitol B7
|
D-myo-inositol-2-O-eicosanoyl-1-O-beta-D-glucopyranoside
|
|
C32H60O12
|
636.408481
|
|
LMFA01170029
|
Octadecanedioic acid
|
Octadecanedioic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA01170029
|
Octadecanedioic acid
|
Octadecanedioic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA01030750
|
2,4,6-trimethyl-2,15-tetracosadienoic acid
|
2,4,6-trimethyl-2,15-tetracosadienoic acid
|
FA 27:2
|
C27H50O2
|
406.381081
|
|
LMFA01030750
|
2,4,6-trimethyl-2,15-tetracosadienoic acid
|
2,4,6-trimethyl-2,15-tetracosadienoic acid
|
FA 27:2
|
C27H50O2
|
406.381081
|
|
LMFA01030736
|
5,8,11,14-Octadecatetraynoic acid
|
5,8,11,14-Octadecatetraynoic acid
|
FA 18:8
|
C18H20O2
|
268.146330
|
|
LMFA01030736
|
5,8,11,14-Octadecatetraynoic acid
|
5,8,11,14-Octadecatetraynoic acid
|
FA 18:8
|
C18H20O2
|
268.146330
|
|
LMFA01170044
|
4E-Decenedioic acid
|
4E-Decenedioic acid
|
FA 10:2;O2
|
C10H16O4
|
200.104860
|
|
LMFA01170044
|
4E-Decenedioic acid
|
4E-Decenedioic acid
|
FA 10:2;O2
|
C10H16O4
|
200.104860
|
|
LMFA03010159
|
1a,1b-dihomo-15-deoxy-delta-12,14-PGD2
|
1a,1b-dihomo-9S-hydroxy-11-oxo-5Z,12E,14E-prostatrienoic acid
|
FA 22:5;O2
|
C22H34O4
|
362.245711
|
|
LMFA02000033
|
2R-HOTrE
|
2R-hydroxy-9Z,12Z,15Z-octadecatrienoic acid
|
FA 18:3;O
|
C18H30O3
|
294.219496
|
|
LMFA02000033
|
2R-HOTrE
|
2R-hydroxy-9Z,12Z,15Z-octadecatrienoic acid
|
FA 18:3;O
|
C18H30O3
|
294.219496
|
|
LMFA02000033
|
2R-HOTrE
|
2R-hydroxy-9Z,12Z,15Z-octadecatrienoic acid
|
FA 18:3;O
|
C18H30O3
|
294.219496
|
|
LMFA04000026
|
(+/-)-8-HDoHE
|
(+/-)-8-hydroxy-4Z,6E,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA04000026
|
(+/-)-8-HDoHE
|
(+/-)-8-hydroxy-4Z,6E,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA04000026
|
(+/-)-8-HDoHE
|
(+/-)-8-hydroxy-4Z,6E,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA07060021
|
3,5,7,9,11,13,15-heptaoxo-hexadecanoyl-[acp]
|
3,5,7,9,11,13,15-heptaoxo-hexadecanoyl-[acp]
|
|
|
|
|
LMFA02000046
|
alpha-12,13-DiHODE
|
(+/-)-12,13-dihydroxy-9Z,15Z-octadecadienoic acid
|
FA 18:2;O2
|
C18H32O4
|
312.230061
|
|
LMFA02000046
|
alpha-12,13-DiHODE
|
(+/-)-12,13-dihydroxy-9Z,15Z-octadecadienoic acid
|
FA 18:2;O2
|
C18H32O4
|
312.230061
|
|
LMFA02000046
|
alpha-12,13-DiHODE
|
(+/-)-12,13-dihydroxy-9Z,15Z-octadecadienoic acid
|
FA 18:2;O2
|
C18H32O4
|
312.230061
|
|
LMFA03010167
|
19R-hydroxy-PGB2
|
9-oxo-15S,19R-dihydroxy-5Z,8(12),13E-prostatrienoic acid
|
FA 20:5;O3
|
C20H30O5
|
350.209326
|
|
LMFA01170061
|
2-hydroxy-2-butenedioic acid
|
2-hydroxy-2-butenedioic acid
|
FA 4:2;O3
|
C4H4O5
|
132.005875
|
|
LMFA01170061
|
2-hydroxy-2-butenedioic acid
|
2-hydroxy-2-butenedioic acid
|
FA 4:2;O3
|
C4H4O5
|
132.005875
|
|
LMFA01170061
|
2-hydroxy-2-butenedioic acid
|
2-hydroxy-2-butenedioic acid
|
FA 4:2;O3
|
C4H4O5
|
132.005875
|
|
LMFA03030000
|
Thromboxanoic acid skeleton
|
|
|
|
|
|
LMFA05000078
|
15-methyl-1,2-eicosanediol
|
15-methyleicosane-1,2-diol
|
FOH 21:0;O
|
C21H44O2
|
328.334131
|
|
LMFA01050362
|
2S-hydroxylauric acid
|
2S-hydroxydodecanoic acid
|
FA 12:0;O
|
C12H24O3
|
216.172545
|
|
LMFA03050036
|
12S-HETrE
|
12S-hydroxy-8Z,10E,14Z-eicosatrienoic acid
|
|
C20H34O3
|
322.250796
|
|
LMFA03050036
|
12S-HETrE
|
12S-hydroxy-8Z,10E,14Z-eicosatrienoic acid
|
|
C20H34O3
|
322.250796
|
|
LMFA03050036
|
12S-HETrE
|
12S-hydroxy-8Z,10E,14Z-eicosatrienoic acid
|
|
C20H34O3
|
322.250796
|
|
LMFA03080028
|
(+/-)14,15-EpETrE-d11
|
14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid
|
|
C20H21D11O3
|
331.304190
|